Agenus to Participate in Fireside Chat at the Jefferies 2021 Virtual Healthcare Conference

Rhea-AI Summary

Agenus (NASDAQ: AGEN) will have its President and COO, Jennifer Buell, PhD, participating in a fireside chat at the Jefferies 2021 Virtual Healthcare Conference. This event is scheduled for June 4, 2021, from 10:30 a.m. to 10:55 a.m. ET. Interested attendees can register in advance for the webinar. A replay of the session will be made available on the Agenus Events & Presentations page following the call. Agenus is focused on immuno-oncology, developing therapies to enhance the immune response against cancer.

LEXINGTON, Mass., June 01, 2021 (GLOBE NEWSWIRE) -- Agenus (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced that Jennifer Buell, PhD, President and COO of Agenus, will participate in a fireside chat at the Jefferies 2021 Virtual Healthcare Conference on Friday, June 4, 2021 from 10:30 a.m. to 10:55 a.m. ET.

Registration for the webinar can be done in advance at https://wsw.com/webcast/jeff174/agen/1824525.

A replay will be available after the call on the Events & Presentations page of the Agenus website at https://investor.agenusbio.com/events-and-presentations.   

About Agenus
Agenus is a clinical-stage immuno-oncology company focused on the discovery and development of therapies that engage the body's immune system to fight cancer. The Company's vision is to expand the patient populations benefiting from cancer immunotherapy by pursuing combination approaches that leverage a broad repertoire of antibody therapeutics, adoptive cell therapies (through its AgenTus Therapeutics subsidiary), and proprietary cancer vaccine platforms. The Company is equipped with a suite of antibody discovery platforms and a state-of-the-art GMP manufacturing facility with the capacity to support clinical programs. Agenus is headquartered in Lexington, MA. For more information, please visit www.agenusbio.com and our Twitter handle @agenus_bio. Information that may be important to investors will be routinely posted on our website and Twitter.

Contact
Agenus Investor Relations
Jan Medina, CFA
Agenus
781-674-4490
Jan.Medina@agenusbio.com

Agenus Media Relations
Kimberly Ha
KKH Advisors
917-291-5744
kimberly.ha@kkhadvisors.com

FAQ

What is the date and time of the fireside chat for Agenus at the Jefferies 2021 Virtual Healthcare Conference?

The fireside chat for Agenus is scheduled for June 4, 2021, from 10:30 a.m. to 10:55 a.m. ET.

Who from Agenus will be participating in the Jefferies 2021 Virtual Healthcare Conference?

Jennifer Buell, PhD, President and COO of Agenus, will participate in the conference.

How can I register to attend the Agenus webinar at the Jefferies Conference?

Registration for the Agenus webinar can be done in advance at the provided link in the press release.

Where can I find the replay of Agenus' fireside chat after the conference?

A replay will be available on the Events & Presentations page of the Agenus website.

What is the focus of Agenus as a company?

Agenus is focused on immuno-oncology, developing therapies that activate the immune system to combat cancer.